Cargando…
Cervical Cancer and Fertility-Sparing Treatment
Radical hysterectomy with pelvic node dissection is the standard treatment for early-stage cervical cancer. However, the latter can be diagnosed at a young age when patients have not yet achieved their pregnancy plans. Dargent first described the vaginal radical trachelectomy for patients with tumor...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585101/ https://www.ncbi.nlm.nih.gov/pubmed/34768345 http://dx.doi.org/10.3390/jcm10214825 |
_version_ | 1784597610205544448 |
---|---|
author | Zaccarini, François Sanson, Claire Maulard, Amandine Schérier, Stéphanie Leary, Alexandra Pautier, Patricia Chargari, Cyrus Genestie, Catherine Gouy, Sébastien Morice, Philippe |
author_facet | Zaccarini, François Sanson, Claire Maulard, Amandine Schérier, Stéphanie Leary, Alexandra Pautier, Patricia Chargari, Cyrus Genestie, Catherine Gouy, Sébastien Morice, Philippe |
author_sort | Zaccarini, François |
collection | PubMed |
description | Radical hysterectomy with pelvic node dissection is the standard treatment for early-stage cervical cancer. However, the latter can be diagnosed at a young age when patients have not yet achieved their pregnancy plans. Dargent first described the vaginal radical trachelectomy for patients with tumors <2 cm. It has since been described a population of low risk of recurrence: patients with tumors <2 cm, without deep stromal infiltration, without lymphovascular invasion (LVSI), and with negative lymph nodes. These patients can benefit from a less radical surgery such as conization or simple trachelectomy with the evaluation of the pelvic node status. Tumors larger than 2 cm have a higher risk of recurrence and their treatment is a challenge. There are currently two options for these patients: abdominal radical trachelectomy or neoadjuvant chemotherapy (NACT), followed by fertility-sparing surgery. All patients who wish to preserve their fertility must be referred to expert centers. |
format | Online Article Text |
id | pubmed-8585101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85851012021-11-12 Cervical Cancer and Fertility-Sparing Treatment Zaccarini, François Sanson, Claire Maulard, Amandine Schérier, Stéphanie Leary, Alexandra Pautier, Patricia Chargari, Cyrus Genestie, Catherine Gouy, Sébastien Morice, Philippe J Clin Med Review Radical hysterectomy with pelvic node dissection is the standard treatment for early-stage cervical cancer. However, the latter can be diagnosed at a young age when patients have not yet achieved their pregnancy plans. Dargent first described the vaginal radical trachelectomy for patients with tumors <2 cm. It has since been described a population of low risk of recurrence: patients with tumors <2 cm, without deep stromal infiltration, without lymphovascular invasion (LVSI), and with negative lymph nodes. These patients can benefit from a less radical surgery such as conization or simple trachelectomy with the evaluation of the pelvic node status. Tumors larger than 2 cm have a higher risk of recurrence and their treatment is a challenge. There are currently two options for these patients: abdominal radical trachelectomy or neoadjuvant chemotherapy (NACT), followed by fertility-sparing surgery. All patients who wish to preserve their fertility must be referred to expert centers. MDPI 2021-10-21 /pmc/articles/PMC8585101/ /pubmed/34768345 http://dx.doi.org/10.3390/jcm10214825 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Zaccarini, François Sanson, Claire Maulard, Amandine Schérier, Stéphanie Leary, Alexandra Pautier, Patricia Chargari, Cyrus Genestie, Catherine Gouy, Sébastien Morice, Philippe Cervical Cancer and Fertility-Sparing Treatment |
title | Cervical Cancer and Fertility-Sparing Treatment |
title_full | Cervical Cancer and Fertility-Sparing Treatment |
title_fullStr | Cervical Cancer and Fertility-Sparing Treatment |
title_full_unstemmed | Cervical Cancer and Fertility-Sparing Treatment |
title_short | Cervical Cancer and Fertility-Sparing Treatment |
title_sort | cervical cancer and fertility-sparing treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585101/ https://www.ncbi.nlm.nih.gov/pubmed/34768345 http://dx.doi.org/10.3390/jcm10214825 |
work_keys_str_mv | AT zaccarinifrancois cervicalcancerandfertilitysparingtreatment AT sansonclaire cervicalcancerandfertilitysparingtreatment AT maulardamandine cervicalcancerandfertilitysparingtreatment AT scherierstephanie cervicalcancerandfertilitysparingtreatment AT learyalexandra cervicalcancerandfertilitysparingtreatment AT pautierpatricia cervicalcancerandfertilitysparingtreatment AT chargaricyrus cervicalcancerandfertilitysparingtreatment AT genestiecatherine cervicalcancerandfertilitysparingtreatment AT gouysebastien cervicalcancerandfertilitysparingtreatment AT moricephilippe cervicalcancerandfertilitysparingtreatment |